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Commentary
Escherichia coli O157:H7 in beef cattle presented for
slaughter in the U.S.: Higher prevalence rates than
previously estimated
Lisa J. Gansheroff and Alison D. O’Brien*
Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799
Before 1982, the Centers for DiseaseControl and Prevention (CDC) had
identified only one Escherichia coli isolate
of the O157:H7 serotype; it had been
isolated from a patient with bloody diar-
rhea (1). Then, in 1982, two outbreaks of
severe bloody diarrhea occurred among
people who had eaten hamburgers at a fast
food chain. The CDC isolated E. coli
O157:H7 from people who had become ill
as well as from a hamburger patty (1). In
1983, Karmali et al. discovered an associ-
ation between infection with E. coli that
produce Shiga toxin (then called Vero
toxin), including O157:H7 strains, and an-
other severe and sometimes fatal condi-
tion, the hemolytic uremic syndrome
(HUS) (2). Last year, the CDC estimated
that strains of E. coli O157:H7 cause ap-
proximately 73,000 illnesses and 60 deaths
per year in the United States, and non-
O157:H7 Shiga toxin-producing E. coli
(STEC) add an additional 37,000 esti-
mated cases (3).
Human infection with E. coli O157:H7
has been associated with a variety of con-
taminated foods, water, and person-to-
person transmission (4–6). Cattle are con-
sidered the primary reservoir of E. coli
O157:H7 that infect humans (Fig. 1).
Adult cattle and weaned calves that carry
E. coli O157:H7 generally remain asymp-
tomatic but shed the bacteria into the
environment in their feces (7, 8). Many of
the foods implicated in human disease are
of bovine origin, and epidemiological
studies have associated the contamination
of crops and water with the use of manure
as fertilizer or with the close proximity of
the vegetable fields or water supplies to
cattle (Fig. 1). In this issue of PNAS, Elder
et al. report the results of their investiga-
tion of the prevalence of E. coli O157
contamination in beef cattle and carcasses
at four different meat processing plants
(9). Their data reveal that the prevalence
of E. coli O157:H7 in cattle and on car-
casses is much higher than previously es-
timated, and the level of carcass contam-
ination correlates with the level of E. coli
O157:H7 in the cattle before processing.
They also found evidence that current
processing practices are reducing contam-
ination levels. However, their study over-
all underscores the need to reduce the
level of E. coli O157:H7 in cattle on the
farm.
E. coli O157:H7 possess a potent com-
bination of virulence factors that undoubt-
edly contributes to its low infectious dose;
additionally, these bacteria survive well
under adverse conditions, such as low pH
(4, 5, 10). The capacity of E. coli O157:H7
to cause bloody diarrhea and HUS derives
from the activity of the Shiga toxins (re-
viewed in refs. 4 and 6). There are two
major types of Shiga toxins expressed by
E. coli associated with human disease,
Stx1 and Stx2. These toxins are structur-
ally similar, and both are cytotoxins that
block eukaryotic translation. Other viru-
lence factors include genes in the locus of
enterocyte effacement (LEE); these fac-
tors allow the bacteria to attach tightly to
mammalian epithelial cells, disrupt the
cytoskeletal structure and signaling path-
ways, and efface the intestinal brush bor-
der to form the characteristic attaching
and effacing lesion (reviewed in ref. 10).
Among the genes on the LEE locus is eae
(originally called eaeA), which encodes
intimin, an outer membrane protein re-
quired for E. coli O157:H7 to adhere to
mammalian cells (10).
In addition to Shiga toxins, eae, and the
O157 serogroup of the O-antigen (the
extracellular branched polysaccharide
that is part of the lipopolysaccharide
coat), another hallmark of this pathogen is
the presence of a large plasmid. Probes for
the hemolysin gene encoded on this plas-
mid have been useful for identifying
O157:H7 strains (11). Most E. coli
O157:H7 lack the capacity to ferment
sorbitol; this trait has also been useful to
microbiologists because it distinguishes
this pathogen from the majority of other
E. coli strains (4, 11). Some O157 strains
do not express functional f lagella (the H
antigen); these bacteria are designated
O157:H2 or O157:NM (nonmotile).
A large number of O157:H7 strains
have been associated with human disease.
Nearly all carry one or more stx genes, eae,
and the large plasmid, but they are distin-
guishable by pulse-field gel electrophore-
sis (PFGE) patterns after restriction en-
zyme digestion and by plaque phenotypes
of a specific set of phage isolated for
typing purposes (11). PFGE and phage
typing have been valuable epidemiological
tools (see Fig. 1) (5, 11).
In earlier studies of the prevalence of E.
coli O157:H7 in dairy and beef cattle,
researchers generally estimated that fewer
than 10% of cattle carry this pathogen;
many estimates were lower than 2% (12).
More sensitive culture techniques have
been developed to detect these bacteria,
and several studies have reported in-
creased prevalence in cattle during
warmer months of the year (11–15). These
data on cattle carriage of O157:H7 corre-
late with the seasonal variation in the
incidence of human disease (4). Thus,
estimates of the prevalence of O157:H7 in
cattle that average isolation rates over
warm and cold seasons or that only in-
clude samplings from cooler months di-
lute the impact of high shedding in the
warmer months. For example, during a
year-long study in England in 1997, E. coli
O157:H7 were isolated from the feces
from as many as 38% of cattle presented
for slaughter in the spring, but only 4.8%
during the winter (15). Similar high prev-
alence rates and seasonal variation were
obtained in recent studies in Canada and
the Netherlands (13, 14).
To determine the prevalence of E. coli
O157:H7 in beef cattle and to assess
whether levels of E. coli O157:H7 in the
cattle presented for slaughter affect the
level of carcass contamination during pro-
cessing, Elder and colleagues assayed cat-
tle and carcasses from four meat process-
ing plants in the United States (9). They
See companion article on page 2999.
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visited each plant twice during July and
August, followed three or four lots of
cattle per plant at each visit, and sampled
at least 20% of each lot. Samples were
taken from hide and feces before process-
ing, and from carcasses at three points
during processing: preevisceration, poste-
visceration, and after anti-microbial inter-
vention steps. Fecal samples from 327
cattle and hide swabs from 357 cattle were
taken, and each of approximately 330
carcasses was sampled at different stages
of the processing procedure.
The enormous number of commensal
microorganisms in the bovine intestinal
tract (16) and the absence of observable
disease caused by E. coli O157:H7 in cattle
present a challenge for detection of this
pathogen. The culture methods used by
Elder et al. incorporate several strategies
that were found to be effective in previous
studies. These include growth of the sam-
ples in broth followed by the use of im-
munomagnetic beads coated with anti-
bodies to the O157 antigen, rather than
direct plating of samples, and the addition
of cefixime and tellurite to the sorbitol-
MacConkey agar (SMACct) used to
screen for sorbitol nonfermenters (11, 13–
15, 17). The broth chosen by Elder et al.
for the initial growth of the fecal samples
was different from the broth used for the
hide and carcass samples. Although they
do not specify their rationale for this
difference in the paper, perhaps these
media were chosen for selectivity against
different background flora that might col-
onize these sites.
After broth enrichment and immuno-
magnetic separation, the organisms were
screened on SMACct. Potential O157 col-
onies were assayed with commercial diag-
nostic products and were confirmed to be
either O157:H7 or O157:NM by monoclo-
nal antibody assays and by direct exami-
nation of motility. Elder et al. note as
unpublished data that their fecal culture
method was more sensitive than two other
diagnostic veterinary procedures when
tested on the same samples, although they
did not specify the steps of these other
methods.
Among the O157:H7 or O157:NM
strains isolated from the cattle and car-
casses, all were positive by PCR for eaeA,
the hemolysin gene, and rfbO157 [a gene
associated with production of the O157
O-antigen (18)]. Additionally, most iso-
lates carried stx2 or both stx2 and stx1; only
1.4% carried stx1 alone, and only one
isolate was stx2. Strains that produce Stx2
or both toxins are more commonly asso-
ciated with human illness than strains that
produce only Stx1 (11). Thus, the strains
isolated from this random sampling of
cattle displayed characteristics similar to
strains associated with human disease.
All but two of the 30 lots tested by
Elder and colleagues contained cattle or
carcasses that were positive for E. coli
O157:H7; there was no clustering of fecal
and hide or carcass prevalence by pro-
cessing plant. Among individual cattle,
the prevalence of E. coli O157:H7 in
fecal samples was 28% overall. This num-
ber is similar to the recent high estimates
obtained in other countries and much
higher than earlier estimates in the U.S.
This result reinforces the concept that
intervention strategies on the farm are
warranted to prevent contamination of
food and water supplies (Fig. 2). The
level of contamination on hides was rel-
atively low; Elder et al. noted that this
was surprising.
When they followed the animals
through processing, they found that 43%
of the carcasses sampled preevisceration
contained E. coli O157:H7 contamination.
They note that this value is much higher
than previous estimates of carcass con-
tamination in the U.S. (19). Among the
postprocessing samples, however, many
fewer (1.8%) were positive. This suggests
that current antimicrobial intervention
strategies in the plants are working.
The total preharvest (fecal and hide)
prevalence correlated with the prevalence
of contamination of carcasses within a
given lot. The correlation suggests that
preharvest infection may influence con-
tamination during processing. The preva-
lence levels detected in the fecal samples
were also generally lower than those de-
tected in the preevisceration carcass sam-
ples from the same lot. This result may
simply indicate that their culture methods
were more sensitive for detecting E. coli
O157:H7 in carcass swabs than in fecal
Fig. 1. Model for transmission of E. coli O157:H7 from cattle to humans. The figure represents data from
numerous studies and depicts examples of the major classes of foods and other sources of E. coli O157:H7
infection that have been reported. The contamination of crops and water sources is associated with the
use of manure in fertilizer or with potential fecal contamination from nearby cattle. The sources of human
infection with E. coli O157:H7 were identified first by epidemiological methods. In some cases, E. coli
O157:H7 was isolated from the suspected food or other source; in many of these cases, including outbreaks
associated with ground meat, PFGE or phage typing provided additional confirmation that the bacteria
isolated from the patient and the suspected food or other source were the same strain. PFGE typing has
also been useful in linking geographically separated outbreaks to a common source of contaminated
meat. The finding of E. coli O157:H7 in birds, deer, and other animals has led to speculation that these
organisms may also be vehicles for O157:H7 transmission. For reviews, see refs. 4–6, 8, and 11.
Fig. 2. Data for infection and shedding are re-
viewed in refs. 5 and 8; the prevalence value (from
fecal samples) is reported by Elder et al. (9) in this
issue of PNAS.
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samples. However, Elder et al. noted that
this finding may reflect some level of
cross-contamination of the carcasses, and
they suggest that preevisceration carcass
contamination may be a critical control
point for further intervention strategies.
The Food Safety and Inspection Service
of the U.S. Department of Agriculture
proposed in 1996 that all meat (and poul-
try) establishments implement Hazard
Analysis and Critical Control Points
(HACCP), a system of controls to reduce
the level of microbial pathogens in food
products (20).
Reducing the amount of E. coli
O157:H7 in live cattle will likely lower
contamination not only of meat but also of
other foods and water supplies that come
into contact with bovine fecal matter. A
variety of strategies have been proposed to
reach this goal. These include modifica-
tion of farm practices and bovine diet (12,
21), vaccination (22, 23), and administra-
tion of lytic phage or probiotic bacteria
(24, 25).
As a final note, although O157:H7 E.
coli are the most important Shiga-toxin
producing E. coli with respect to human
disease in the United States, other STEC
strains are emerging as important patho-
gens in the U.S. and throughout the world.
These include E. coli of non-O157 sero-
types as well as O157 strains that can
ferment sorbitol (3, 11). The increased
prevalence of E. coli O157:H7 found by
Elder et al. with improved detection meth-
ods raises the question of the actual prev-
alence of these other pathogens.
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